002630.KS
ORIENT BIO Inc.
KSC · Healthcare · Biotechnology · KR
KRW 913.00
+8.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.60x
- Price / sales
- 3.66x
- Price / cash flow
- 79.68x
Enterprise value
- Enterprise value
- KRW 78.1B
- EV / sales
- 2.64x
- EV / EBITDA
- -13.78x
- EV / EBIT
- -17.55x
- Market cap
- KRW 108.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025